OFLOCET 1.5 mg/0.5 ml, ear solution in a single-dose container 20 single-dose containers of 0.5 ml
Active ingredients: OFLOXACINE
Commercialized according to BDPMDispensing in France: Prescription only
Solution20 single-dose containers of 0.5 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OFLOCET 1,5 mg/0,5 ml, solution auriculaire en récipient unidose
- Pharmaceutical form
- solution
- Route of administration
- auriculaire
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène de 0,5 ml
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68399214CIP73398635CIP133400933986353Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OFLOXACINEsolution | 1,5 mg · un récipient unidose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: OFLOXACINE 1,5 mg/0,5 ml - OFLOCET 1,5 mg/0,5 ml, solution auriculaire en récipient unidose.